Results Press Release for December 31, 2016
Themis Medicare Ltd has informed BSE about : 1. Result Press Release for the period ended December 31, 201615-02-2017
15-02-2017
Outcome of Board Meeting
Themis Medicare Ltd has informed BSE that the Board of Directors of the Company at its meeting held on February 14, 2017, inter alia, has approved the following;1. Appointed Dr. Sachin D. Patel as Managing Director & CEO of the Company w.e.f. February 14, 2017 at revised remuneration subject to approval by members in the ensuing AGM.2. Dr. Dinesh S. Patel re-designated as Executive Vice-Chairman of the Company w.e.f. February 14,...14-02-2017
Standalone & Consolidated Financial Results, Limited Review Report for December 31, 2016
Themis Medicare Ltd has informed BSE about : 1. Standalone Financial Results for the period ended December 31, 20162. Consolidated Financial Results for the period ended December 31, 20163. Standalone Limited Review for the period ended December 31, 20164. Consolidated Limited Review for the period ended December 31, 201614-02-2017
Board Meeting Intimation for Results & Closure of Trading Window
Themis Medicare Ltd has informed BSE that the meeting of the Board of Directors of the Company is scheduled to be held on February 14, 2017, inter alia, to consider and approve the unaudited Financial Results for the quarter/nine months ended on December 31, 2016.Further, the Trading Window in respect of the Company's Securities shall remain closed for all Directors/Officer/Designated Employees of the Company from the opening of the trading...03-02-2017
Shareholding for the Period Ended December 31, 2016
Themis Medicare Ltd has submitted to BSE the Shareholding Pattern for the Period Ended December 31, 2016. For more details, kindly Click here16-01-2017
Statement of Investor Complaint under Reg. 13(3) of SEBI (LODR) Regulations, 2015 for Quarter ended December 31, 2016
Themis Medicare Ltd has informed BSE regarding Quarterly Statement on Investor Complaints / Grievances Redressal Mechanism for the Quarter ended December 31, 2016, under Regulation 13(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.13-01-2017
Change in Directorate
Themis Medicare Ltd has informed BSE that the Company has received resignation letter from Ms. Dharmisthaben Raval dated December 22, 2016 with immediate effect due to personal reasons. Ms. Dharmisthaben N. Raval was associated with the Company as an Independent Woman Director on the Board.23-12-2016
Results Press Release for September 30, 2016
Themis Medicare Ltd has informed BSE about : 1. Result Press Release for the period ended September 30, 201610-11-2016
Standalone & Consolidated Financial Results, Limited Review Report for September 30, 2016
Themis Medicare Ltd has informed BSE about : 1. Standalone Financial Results for the period ended September 30, 20162. Consolidated Financial Results for the period ended September 30, 20163. Standalone Limited Review for the period ended September 30, 20164. Consolidated Limited Review for the period ended September 30, 201608-11-2016
Outcome of Board Meeting
Themis Medicare Ltd has informed BSE that the Board of Directors of the Company at its meeting held on November 08, 2016, inter alia, has perused and approved the following matters:1. Allotment of 1000 Equity shares to eligible employee pursuant to exercise of ESOP options under Themis ESOS Scheme 2012.2. The Board also approved a proposal to establish a Wholly Owned Subsidiary (WOS) in Europe.Meeting Commencement time - 11.30 AMMeeting Conclusion Time - 1.45 PM08-11-2016